- Home
- AHG
as 04-03-2025 4:00pm EST
Akso Health Group formerly Xiaobai Maimai Inc is a social e-commerce platform based in China. The company collaborates with domestic e-commerce platforms and offers users a wide selection of high-quality and affordable products on its social e-commerce platform. It generates majority of the revenues from sale of medical devices business.
| Founded: | 2013 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 502.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $2.35 | Next Earning Date: | 04-11-2025 |
| Revenue: | $8,454,946 | Revenue Growth: | 281.19% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Akso Health Group ADS News
AHG Breaking Stock News: Dive into AHG Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Akso Health Group (NASDAQ:AHG) investors are sitting on a loss of 27% if they invested three years ago
PR Newswire
a month ago
AHG Utilizes DeepSeek to Advance AI in Healthcare
Simply Wall St.
5 months ago
Estimating The Intrinsic Value Of Akso Health Group (NASDAQ:AHG)
Simply Wall St.
6 months ago
Akso Health Group (NASDAQ:AHG) shareholders are up 24% this past week, but still in the red over the last five years
Simply Wall St.
8 months ago
Akso Health Group Full Year 2024 Earnings: US$0.19 loss per share (vs US$0.58 loss in FY 2023)
GlobeNewswire
a year ago
AHG Announces Plan to Acquire Online Clinic
Simply Wall St.
a year ago
The 36% return this week takes Akso Health Group's (NASDAQ:AHG) shareholders one-year gains to 271%
Zacks
a year ago
Strength Seen in Avidity Biosciences, Inc. (RNA): Can Its 15.0% Jump Turn into More Strength?
Compare AHG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AHG Akso Health Group ADS - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.